Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels

Androgenic to oestrogenic switch in the human adult prostate gland is regulated by epigenetic silencing of steroid 5α-reductase 2

(2017) Zongwei Wang et al.   JOURNAL OF PATHOLOGY

Modifications of Western-type diet regarding protein, fat and sucrose levels as modulators of steroid metabolism and activity in liver

(2017) Agata Krawczyńska et al.   JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY

Single-nucleotide polymorphism in the 5-α-reductase gene ( SRD5A2 ) is associated with increased prevalence of metabolic syndrome in chemotherapy-treated testicular cancer survivors

(2016) Hink Boer et al.   EUROPEAN JOURNAL OF CANCER

Dual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man

(2016) Jonathan M. Hazlehurst et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Association of Benign Prostate Hyperplasia with Polymorphisms in VDR, CYP17, and SRD5A2 Genes among Lebanese Men

(2014) Asmahan Ali El Ezzi et al.   Asian Pacific Journal of Cancer Prevention

ICAM-1 and SRD5A1 gene polymorphisms in symptomatic peripheral artery disease

(2014) Vincenza Barresi et al.   VASCULAR MEDICINE

Importance of 5α-Reductase Gene Polymorphisms on Circulating and Intraprostatic Androgens in Prostate Cancer

(2013) Éric Lévesque et al.   CLINICAL CANCER RESEARCH

Current perspectives on the androgen 5 alpha-dihydrotestosterone (DHT) and 5 alpha-reductases in teleost fishes and amphibians

(2013) Christopher J. Martyniuk et al.   GENERAL AND COMPARATIVE ENDOCRINOLOGY

SRD5A1 and SRD5A2 are Associated with Treatment for Benign Prostatic Hyperplasia with the Combination of 5α-Reductase Inhibitors and α-Adrenergic Receptor Antagonists

(2013) Xin Gu et al.   JOURNAL OF UROLOGY

The Correlation Between Metabolic Syndrome and Prostatic Diseases

(2011) Cosimo De Nunzio et al.   EUROPEAN UROLOGY

Long-Term Treatment With Finasteride Improves Clinical Progression of Benign Prostatic Hyperplasia in Men With an Enlarged Versus a Smaller Prostate: Data From the MTOPS Trial

(2011) Steven A. Kaplan et al.   JOURNAL OF UROLOGY

Association of polymorphisms in CYP19A1 and CYP3A4 genes with lower urinary tract symptoms, prostate volume, uroflow and PSA in a population-based sample

(2009) Richard Berges et al.   WORLD JOURNAL OF UROLOGY

Serum Steroid and Sex Hormone-Binding Globulin Concentrations and the Risk of Incident Benign Prostatic Hyperplasia: Results From the Prostate Cancer Prevention Trial

(2008) A. R. Kristal et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Pathology of benign prostatic hyperplasia

(2008) C G Roehrborn   INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH